Neoantigen identification and TCR-T therapy development for solid tumors: current advances and future perspectives
{{output}}
Recently, T cells expressing engineered T cell receptor (TCR-T cells) have become recognized as a promising tumor cell therapy for solid tumors because of their ability to selectively kill tumor cells with less destruction of other cells and their high safety ... ...
